More on Varian Medical Systems (VAR): Q1 comes in mixed, missing on the bottom line but beating on revenue. Oncology Systems and X-Ray Products businesses both grew 8% and 18% respectively Y/Y, with margins in line with expectations. The company lowers guidance for Q2 and FY13 however, now expecting Q2 EPS to be $0.98 - $1.03, versus the consensus of $1.04. For FY13, it anticipates EPS of $4.08 - $4.16. The Street view is for an EPS of $4.24. Shares -4.3% AH.